Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Build A Bear Workshop Inc (BBW) vs Sana Biotechnology Inc (SANA) Price & Performance

Build A Bear Workshop IncTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Build A Bear Workshop Inc vs Sana Biotechnology Inc — how do they compare? Build A Bear Workshop Inc trades at $32.95 (market cap $412.61M), while Sana Biotechnology Inc trades at $3.58 (market cap $994.89M). The key difference: Sana Biotechnology Inc is far larger — about 2.4× Build A Bear Workshop Inc's market cap, and Build A Bear Workshop Inc pays a 2.8% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.

BBWSANA
Market Cap
$412.61M$994.89M
Sector
Consumer CyclicalHealth
52-Week High
$75.85$5.92
52-Week Low
$29.84$2.68
Enterprise Value
$512.05M$969.08M
Dividend Yield
2.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Build A Bear Workshop Inc

Build-A-Bear Workshop (BBW) trades at $33.62, down 2.32% with a bullish technical signal and strong valuation metrics including a P/E of 7.71 and P/S of 0.81. The company maintains solid profitability with 10.48% net margins and 35.87% ROE, while recent earnings have consistently beaten expectations. CEO transition to Chris Hurt in June 2026 and new product launches support growth initiatives.

BBW presents compelling value with analyst consensus target of $62.50 (86% upside) and 73% buy ratings. Strong fundamentals and debt-free balance sheet support long-term growth, though near-term headwinds include consumer spending pressure and international expansion execution risks.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.64, down 5.45% over 24 hours, with a bullish technical signal and strong analyst support (81.82% buy ratings). Recent news highlights clinical progress, including NEJM publications and conference presentations, but financials show significant losses with a net income of -$244.17M in 2025 and negative cash flows.

The outlook is mixed: strong scientific momentum and Wall Street optimism contrast with deep financial losses and high burn rate. Key risks include funding needs and clinical trial outcomes, while potential upside hinges on successful product development and partnerships.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Build A Bear Workshop Inc

Build-A-Bear is a global retailer specializing in customizable stuffed animals. It offers an interactive make-your-own experience where customers choose, stuff, and dress their furry friends in-store or online.

Read more on BBW

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA